Abivax S.A.

ABVX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $9.3B · 69 employees
33
SEC Filings
$114.79
Close 2026-09-04
69
Employees

Business Summary

Abivax S.A. is a clinical-stage biopharmaceutical company incorporated in France in 2013. The company focuses on developing drug candidates for inflammatory diseases, with its lead candidate obefazimod currently in clinical trials. Abivax has no approved products or product revenues to date, and has reported net losses of €336.1 million, €176.2 million, and €147.7 million for the years ended December 31, 2025, 2024, and 2023, respectively.

Latest Stock Quote

ABVX 2026-09-04 $114.79 O:$114.15 H:$115.33 L:$112.782 Vol:0.5M VWAP:$114.309
origin leaf: null

33 total filings indexed. 33 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

inflammatory-diseases biopharmaceuticals clinical-stage-drug-development

Company Identity

CIK0001956827
TickerABVX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedI0
Websitehttps://www.abivax.com
Listed2023-10-20

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: eb9db4defdbc34c091458dc3469c0f8c0ddf0697a1ac13be50e933769e46b312
parent: root
content hash: b662fe267d0e8f0fc27be86da0f0579360b46509afd78c233b27e071c4842df1
signed: 2026-09-30T12:00:06.902Z
sources: 0 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ABVX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ABVX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ABVX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.